These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8041892)

  • 21. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
    Moĭseieva HV; Zadorozhna VI
    Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined OPV and IPV program in control of poliomyelitis in two endemic areas--a potential tool in the struggle to eradicate poliomyelitis.
    Tulchinsky TH
    Public Health Rev; 1993-1994; 21(1-2):153-6. PubMed ID: 8041883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine policy changes and epidemiology of poliomyelitis in the United States.
    Alexander LN; Seward JF; Santibanez TA; Pallansch MA; Kew OM; Prevots DR; Strebel PM; Cono J; Wharton M; Orenstein WA; Sutter RW
    JAMA; 2004 Oct; 292(14):1696-701. PubMed ID: 15479934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The perspective of global eradication of poliomyelitis].
    Knolle H; Egli A; Candrian U
    Gesundheitswesen; 2004 Jan; 66(1):1-6. PubMed ID: 14767784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on vaccine-derived polioviruses--worldwide, July 2009-March 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(25):846-50. PubMed ID: 21716199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016.
    Hampton LM; Farrell M; Ramirez-Gonzalez A; Menning L; Shendale S; Lewis I; Rubin J; Garon J; Harris J; Hyde T; Wassilak S; Patel M; Nandy R; Chang-Blanc D;
    MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(35):934-8. PubMed ID: 27606675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Possible method of eradication of poliomyelitis as an infection].
    Seĭbil' VB; Malyshkina LP
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (3):107-13. PubMed ID: 22830285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost-effectiveness of alternative polio immunization policies in South Africa.
    Griffiths UK; Botham L; Schoub BD
    Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful control of poliomyelitis by a combined OPV/IPV polio vaccine program in the West Bank and Gaza, 1978-93.
    Tulchinsky T; Abed Y; Handsher R; Toubassi N; Acker C; Melnick J
    Isr J Med Sci; 1994; 30(5-6):489-94. PubMed ID: 8034509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience with poliovaccines in the control of poliomyelitis in India.
    John TJ
    Public Health Rev; 1993-1994; 21(1-2):83-90. PubMed ID: 8041891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas.
    Tulchinsky T; Abed Y; Shaheen S; Toubassi N; Sever Y; Schoenbaum M; Handsher R
    Am J Public Health; 1989 Dec; 79(12):1648-52. PubMed ID: 2817193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of poliomyelitis--options and update.
    Dutta A
    Vaccine; 2008 Oct; 26(45):5767-73. PubMed ID: 18755232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP).
    Alexander L; Birkhead G; Guerra F; Helms C; Hinman A; Katz S; LeBaron CW; Modlin J; Murphy TV; ;
    Arch Pediatr Adolesc Med; 2004 Dec; 158(12):1106-12. PubMed ID: 15583093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines.
    Bull World Health Organ; 1996; 74(3):253-68. PubMed ID: 8789924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The golden jubilee of vaccination against poliomyelitis.
    John TJ
    Indian J Med Res; 2004 Jan; 119(1):1-17. PubMed ID: 14997988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress toward poliomyelitis eradication--Africa, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Apr; 46(15):321-5. PubMed ID: 9132585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivated polio vaccine: time to introduce it in India's national immunization schedule.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2012 Jul; 8(7):956-8. PubMed ID: 22699444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methods for poliomyelitis eradication: is there a consensus?
    Beale AJ
    Public Health Rev; 1993-1994; 21(1-2):129-34. PubMed ID: 8041878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strengths and weaknesses of current polio vaccines--a view from industry.
    André FE
    Dev Biol (Basel); 2001; 105():61-6. PubMed ID: 11763338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.